Dr Mel Sorensen
-
Stock of Malvern-Based Biopharmaceutical Company Takes a Dive After Disappointing Trial for Its Lead Therapy
Malvern-based Galera Therapeutics’ stock fell by more than 70 percent after the biopharmaceutical firm announced that its cancer drug candidate did not meet its primary…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
